English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
GSK deal with Idera for renal R&D
2015-11-27
GlaxoSmithKline ($GSK) is taking a gamble on Idera Pharmaceuticals' ($IDRA) antisense drug technology, promising up to $100 million in a collaboration focused on renal disease. Under the deal, GSK is paying it..
Vela,Gustave Roussy Deal On Tumor Testing
2015-11-27
Vela Diagnostics today announced a collaboration with France's Gustave Roussy Institute of Oncology on next-generation based cancer testing. The collaboration will focus on both solid and liquid tumor diagn..
US Representatives Sign Letter Calling for Increased NIH Funding
2015-11-26
A group of more than 100 members of the US House of Representatives yesterday signed a letter urging the House Committee on Appropriations work with the US Senate to boost fiscal 2016 funding for the National Institut..
Horizon, Axol Deal On iPSCs
2015-11-26
Horizon Discovery has formed a strategic partnership with Axol Bioscience to develop and commercialize genomically modified and differentiated induced pluripotent stem cells (iPSCs) for neuronal and cardiovascular res..
Beckman Coulter, IncellDx Ink Distribution Pact in Asian Countries
2015-11-26
Beckman Coulter Life Sciences and IncellDx have signed a distribution agreement focusing on human papillomavirus and cancer research in China, Hong Kong, and Taiwan. Under the agreement, IncellDx's investig..
Biocept Inks Two New Deals With PPOS
2015-11-25
Biocept today announced that it has signed two new agreements with preferred provider organization networks — Fortified Provider Network and Three Rivers Provider Network. Under the deals, the approximate..
Roche acquired Adheron Therapeutics with $580
2015-11-25
Recently, Roche acquired Adheron Therapeutics with $580 million for enhancing the immune research. The shareholders of Adheron Therapeutics get $150 million cash, the other $475 million will be paid after they ..
NIH Earmarks $48.2M for Progenitor Cell Translational Research Consortium
2015-11-25
The National Institutes of Health announced that it will commit as much as $40 million over the next seven years to fund the creation of the National Heart, Lung, and Blood Institute Progenitor Cell Translational Cons..
Gene Expression Informatics Companies Collaborate on Diagnostics of Age-Related Diseases
2015-11-24
Affymetrix, Inc. (Santa Clara, CA, USA) and XRGenomics LTD (Nottingham, UK) have announced a partnership to collaborate on research and development of a new generation of diagnostic tests for age-related diseases. ..
Diagnostics companies jump into rapidly growing market for POC superbug tests
2015-11-24
As the number of drug-resistant superbug infections continues to rise, diagnostics companies are rolling out rapid, point-of-care devices that can quickly identify infectious bacteria and potentially cut down on the n..
In Brief This Week: Meridian Bioscience; Agilent; Alere
2015-11-24
Meridian Bioscience announced this week that the US Food and Drug Administration has cleared new claims for the firm's illumigene Pertussis molecular amplification test. The new claims include specimens collected ..
Thermo Fisher Inks Companion Dx Deal With Novartis, Pfizer
2015-11-23
Nov 18, Thermo Fisher Scientific said that it has entered into a long-term agreement with Novartis and Pfizer to develop and commercialize a multi-marker, next-generation sequencing-based companion diagnostic test. Th..
Merck KGaA Buys Sigma-Aldrich for $17B
2015-11-23
Germany's Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission. The deal creates a science sector giant that will "co..
Diatherix, Color Genomics Receive CAP Accreditation
2015-11-23
Diatherix Laboratories, a Eurofins subsidiary, and Color Genomics have both announced accreditation from the College of American Pathologists. To receive accreditation inspectors examined several laboratory co..
Shenzhen Kangmei Listing on The New OTC Market
2015-11-20
NOV 17,Shenzhen Kangmei Biotechnology Co., Ltd apply for list on the new OTC market. The details show’s Shenzhen Kangmei was established in Dec 29, 2007. Mr. Bi Shaohui, the chairman of Shenzhen Kangmei account..
Total:
3545
Pages:
237
First
Prev
1
..
220
221
222
223
224
225
226
..
237
Next
End